Centaurus Financial’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-25,065
| Closed | -$834K | – | 972 |
|
|
2021
Q3 | $834K | Buy |
25,065
+65
| +0.3% | +$2.16K | 0.07% | 306 |
|
|
2021
Q2 | $970K | Sell |
25,000
-1,000
| -4% | -$38.8K | 0.08% | 278 |
|
|
2021
Q1 | $1.25M | Hold |
26,000
| – | – | 0.12% | 202 |
|
|
2020
Q4 | $1.35M | Hold |
26,000
| – | – | 0.14% | 176 |
|
|
2020
Q3 | $696K | Buy |
26,000
+6,000
| +30% | +$161K | 0.1% | 228 |
|
|
2020
Q2 | $390K | Buy |
20,000
+5,000
| +33% | +$97.5K | 0.06% | 303 |
|
|
2020
Q1 | $148K | Buy |
15,000
+5,000
| +50% | +$49.3K | 0.03% | 407 |
|
|
2019
Q4 | $111K | Hold |
10,000
| – | – | 0.02% | 591 |
|
|
2019
Q3 | $56K | Hold |
10,000
| – | – | 0.01% | 440 |
|
|
2019
Q2 | $87K | Buy |
10,000
+9,920
| +12,400% | +$86.3K | 0.01% | 584 |
|
|
2019
Q1 | $10K | Buy |
+80
| New | +$10K | 0.06% | 261 |
|